Is There a Use for Nesiritide in Pediatric Patients?

1. Struthers AD. Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use? BMJ. 1994;308: 1615-1619 .

2. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain . Nature. 1988;332: 78-81 .

3. DeBold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats . Life Sci. 1981;28: 89-94 .

4. Yasue H, Yoshimura H, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure . Circulation. 1994;90: 195-203 .

5. Silver MA, Horton DP, Ghali JK, Elkayam U. Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure . J Am Coll Cardiol. 2002;39(5): 798-803 .

6. Keating GM, Goa KL. Nesiritide: a review of its use in acute decompensated heart failure . Drugs. 2003;63(1): 47-70 .

7. Colluci WS, Elkayam U, Horton DP, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure . N Engl J Med. 2000;343(4): 246-253 .

8. Publication Committee for the VMAC Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure . JAMA. 2002;287(12): 1531-1540 .

9. Burger AJ, Horton DP, LeJemtel T, et al. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study . Am Heart J. 2002;144(6): 1102-1108 .

10. Abraham WT, Adams KF, Fonarow GC, et al. Comparison of in-hospital mortality in patients treated with nesiritide vs other parental vasoactive medications for acutely decompensated heart failure: an analysis from a large prospective registry database . J Card Fail. 2003;9(5 suppl 1): 412 .

11. Chen HH, Redfield MM, Schirger JA, et al. Chronic subcutaneous administration of BNP in human heart failure for eight weeks: a pilot study to establish safety and lack of tolerance . J Card Fail. 2003;9(5 suppl 1): 525 .

12. Mulki GM, Pisano C, Colleen G, et al. Safety and efficacy of intermittent, short-term, outpatient nesiritide infusions for the treatment of decompensated heart failure . J Card Fail. 2003;9(5 suppl 1): 559 .

13. Sehra R, Underwood KR. Nesiritide improves urine output in severely ill pediatric patients awaiting heart transplantation without severe hypotension . J Card Fail. 2003;9(5 suppl 1): 175 .

14. Marshall J, Berkenbosch JW, Russo P, Tobias JD. Preliminary experience with nesiritide in the pediatric population . J Intensive Care Med. 2004;19: 164-170 .